This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft. Active years: 2021-2025.
Company Filing History:
2 out of 12,266 
1 out of 386 
Years Active: 2021-2025
Title: Andre Philippe Dieskau: Innovator in Pharmaceutical Chemistry
Introduction
Andre Philippe Dieskau is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating various cardiovascular and renal diseases. With a total of two patents to his name, Dieskau's work is recognized for its potential impact on medical treatments.
Latest Patents
Dieskau's latest patents include "Substituted pyrazolo piperidine carboxylic acids," which relates to the preparation and use of these compounds for creating medicaments targeting cardiovascular diseases, hypertension, and other serious health conditions. His second patent, "Substituted 6-(1H-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereof," covers compounds that are useful in treating cardiovascular and renal diseases, either alone or in combination with other active ingredients.
Career Highlights
Throughout his career, Andre Philippe Dieskau has worked with prominent companies such as Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical research.
Collaborations
Dieskau has collaborated with notable colleagues, including Carsten Schmeck and Alexandros Vakalopoulos, who have contributed to his research endeavors.
Conclusion
Andre Philippe Dieskau's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in medical treatments for critical health issues.